Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
1.8400+0.0650 (+3.66%)
At close: 09:55AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.7750
Open1.8400
BidN/A x N/A
AskN/A x N/A
Day's Range1.8400 - 1.8400
52 Week Range1.2800 - 2.1000
Volume3,526
Avg. Volume2,306
Market Cap7.907B
Beta (5Y Monthly)0.25
PE Ratio (TTM)6.09
EPS (TTM)0.3020
Earnings DateN/A
Forward Dividend & Yield0.06 (4.64%)
Ex-Dividend DateJul 20, 2022
1y Target EstN/A
  • GlobeNewswire

    aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update

    Company to present clinical data for efzofitimod (ATYR1923) in pulmonary sarcoidosis at upcoming American Thoracic Society International Conference in May. Planned registrational study of efzofitimod in pulmonary sarcoidosis on track to initiate in the third quarter of 2022. FDA granted orphan drug designation for efzofitimod for the treatment of systemic sclerosis; company to explore potential expansion of clinical program in other ILD. Ended the first quarter 2022 with $98.7 million in cash, c

  • ACCESSWIRE

    Love Hemp Group PLC Announces Update Regarding Trading Suspension

    LONDON, UK / ACCESSWIRE / May 9, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, wishes to provide an update on the temporary suspension of the trading in shares of Love Hemp.As previously announced, the reason for the suspension is that Peterhouse Capital Limited ("Peterhouse") has resigned as the AQSE Corporate Advisor and the Company needs to appoint a new AQSE Corporate Advisor in order that trading can

Advertisement
Advertisement